Non-compliance and its management in teenagers

Pediatric Transplantation

Volumn 6, Issue 6, 2002, Pages 475-479

  Nevins, Thomas E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adherence; Adolescence; Kidney; Medication compliance; Transplantation

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENCE; ADOLESCENT; CADAVER DONOR; CONFERENCE PAPER; COPING BEHAVIOR; DIALYSIS; DISEASE SEVERITY; DRUG MONITORING; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PATIENT COMPLIANCE; PATIENT EDUCATION; SIDE EFFECT;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT PSYCHOLOGY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PATIENT COMPLIANCE; TREATMENT REFUSAL;

EID: 0036905467     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.149.ptr1s077.1.x     Document Type: Conference Paper

References (20)

1. Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991.
2. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979.
3. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplant 1995: 59: 340-347.
4. Raiz LR, Kilty KM, Henry ML, Ferguson RM. Medication compliance following renal transplantation. Transplant 1999: 68: 51-55.
5. Didlake R, Dreyfus K, Kerman R, et al. Patient non-compliance: A major cause of late graft failure in cyclosporine-treated transplants. Transplant Proc 1988: 20 (Suppl. 3): 63-69.
6. Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: A review. J Am Soc Nephrol 1999: 10: 1366-1380.
7. Gordis L, Markowitz M, Lilienfeld AM. Studies in the epidemiology and preventability of rheumatic fever. Pediatrics 1969: 43: 173-182.
8. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? JAMA 1989: 261: 3273-3277.
9. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthamol 1986: 101: 515-523.
10. Lang JM, Buring JE, Rosner B, Cook N, Hennekens CH. Estimating the effect of the run-in on the power of the physicians' health study. Stat Med 1991: 10: 1585-1593.
11. Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001: 60: 1565-1570.
12. Kruse W, Weber E. Dynamics of drug regimen compliance - Its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990: 38: 561-565.
13. Friedman IM, Litt IF. Adolescents' compliance with therapeutic regimens. J Adolesc Health Care 1987: 8: 52-67.
14. Korsch BM, Fine RN, Negrete VF. Noncompliance in children with renal transplants. Pediatrics 1978: 61: 872-876.
15. Warady BA, Mudge C, Wiser B, Wiser M, Rader B. Transplant allograft loss in the adolescent patient. Adv Ren Replace Ther 1996: 3: 154-165.
16. Cole BR. Noncompliance to medical regimens. In: Tejani AH, Fine RN, eds. Pediatric Renal Transplantation. New York: Wiley-Liss, 1994, pp. 397-408.
17. Urquhart J. Correlates of variable patient compliance in drug trials: Relevance in the new health care environment. Adv Drug Res 1995: 26: 237-257.
18. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990: 150: 1881-1884.
19. Cramer JA, Rosenheck R. Enhancing medication compliance for people with serious mental illness. J Nerv Ment Dis 1999: 187: 53-55.
20. Cramer JA, Scheyer RS, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990: 150: 1509-1510.